Latest News

Latest News

News from the World Hepatitis Alliance

290 million worldwide unaware they are living with deadly virus

28 Jul 2018 Bridie Taylor

New data released on World Hepatitis Day reveals barriers that leave 9 in 10 people living with viral hepatitis undiagnosed and untreated World...

World Hepatitis Alliance and InTec partner to Find the Missing Millions

28 Jul 2018 Bridie Taylor

Global diagnostic manufacturer donates 25,000 hepatitis C tests on World Hepatitis Day [World Hepatitis Alliance, London, 28 July 2018] On World...

Join the Quest to Find the Missing Millions on World Hepatitis Day 2018

22 Jun 2018 Bridie Taylor

The Quest to Find the Missing Millions has begun! The Quest to Find the Missing Millions is an online hub with ideas and information for...

JUNE 2018: HEP HEADLINES

6 Jun 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. WHO reports progress on global...

MAY 2018: HEP HEADLINES

2 May 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. Founder of the World Hepatitis Alliance...

Founder of the World Hepatitis Alliance appointed as Executive Director of the Medicines Patent Pool

19 Apr 2018 Bridie Taylor

Charles Gore continues his legacy of improving access to treatment for people living with hepatitis B and C Today the Medicines Patent Pool (MPP)...

APRIL 2018: HEP HEADLINES

13 Apr 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. World Hepatitis Day 2018 campaign to...

World Hepatitis Alliance poised to “Find the Missing Millions” on World Hepatitis Day

28 Mar 2018 Bridie Taylor

Today, the World Hepatitis Alliance (WHA) launched this year’s World Hepatitis Day campaign entitled “Find the Missing Millions”. Under the theme of...

Hepatitis C among people who use drugs – Side Event at the Commission on Narcotic Drugs

12 Mar 2018 Bridie Taylor

The prevalence of hepatitis C among people who use drugs remains extremely high. However, the remarkable progress in science and medicine along with...

Close to 3 million access hepatitis C cure

9 Mar 2018 Bridie Taylor

On 8 March 2018, WHO launched the "Progress report on access to hepatitis C treatment" which is an update on the first edition, published in 2016. It...

MARCH 2018: HEP HEADLINES

2 Mar 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. Malta steps up elimination efforts...

February 2018: Hep Headlines

6 Feb 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. WHA welcomes a New President: Michael...

Deaths from liver cancer nearly double since the 1990s, new figures reveal

1 Feb 2018 Tara Farrell

[London, 1 February 2018] Over the last two decades, deaths caused by liver cancer have increased by 80% [1] , making it one of the fastest-growing...

Charles Gore steps down as WHA President

15 Dec 2017 Bridie Taylor

“After ten years as President of the World Hepatitis Alliance (WHA), my term has come to an end and I step down at the end of this year. As the World...

Worldwide 52 million children living with viral hepatitis

3 Nov 2017 Tara Farrell

World Hepatitis Alliance calls for better screening expectant mothers and treatment of children New data presented at this year’s World Hepatitis...

Miracle cure costs less than a budget airline flight

2 Nov 2017 Tara Farrell

New data shows hepatitis C cure can cost as low as 50 dollars, and data from over 1,000 patients shows it’s highly effective Embargo: 0001H Sao Paulo...

Nine countries now on track to eliminate hepatitis C

1 Nov 2017 Tara Farrell

On 1- 3 November, Ministers of Health, public health experts and NGOs will come together at the World Hepatitis Summit to advance the elimination of...

Viral Hepatitis kills more people than HIV, malaria or tuberculosis

15 Sep 2017 Tara Farrell

World Hepatitis Alliance calls for immediate political action to counteract fatal trend [London, 14 September] According to the Global Burden of...

Hepatitis A vaccination for Alaskan children has wiped out the virus

10 Aug 2017 Tara Farrell

A comprehensive hepatitis A vaccination program established in Alaska in the 1990s, which became a requirement for school entry in 2001, has...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska’s young people

10 Aug 2017 Tara Farrell

Updated research presented at this year’s World Indigenous Peoples’ Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that...

Pages

News from infohep

DAA treatment reduces the risk of death and liver cancer in France

12 Feb 2019 Keith Alcorn
Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with...

Tackling HIV and hepatitis C in Europe: towards minimum standards

11 Feb 2019 Gus Cairns
Despite the huge disparities in care that were highlighted, last week's Standard of Care for HIV and Coinfections in Europe meeting in...

Hepatitis C cure does not improve glucose control in type 2 diabetes

7 Feb 2019 Michael Carter
A successful response to hepatitis C virus (HCV) therapy does not result in long-term improvements in glucose metabolism for people with type 2...

Immunotherapy combinations show promise for liver cancer

4 Feb 2019 Liz Highleyman
Checkpoint inhibitor immunotherapy combinations may slow disease progression in people with hepatocellular carcinoma (HCC), according to two small...

Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost

1 Feb 2019 Michael Carter
Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (...

Experimental therapy improves liver health in people with fatty liver disease

31 Jan 2019 Liz Highleyman
NGM282, an experimental fibroblast growth factor analogue, reduced liver fat build-up and the development of scar tissue in people with non-alcoholic...

WHO hepatitis C elimination targets are achievable, model shows – if 51 million treated by 2030

29 Jan 2019 Keith Alcorn
Expanding hepatitis C screening to diagnose 90% of people by 2030, providing treatment to everyone with hepatitis C, scaling up harm reduction and...

HIV infection an independent risk factor for poorer survival from liver cancer

28 Jan 2019 Michael Carter
Infection with HIV is associated with significantly worse survival for people with hepatocellular carcinoma (HCC, the most common type of...

Conditional cash transfers may improve HCV screening and treatment in drug users

22 Jan 2019 Keith Alcorn
Conditional cash transfers – giving money to encourage use of services – may be needed to reach drug users for hepatitis C testing and treatment if...

Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins

16 Jan 2019 Keith Alcorn
Despite access to hepatitis C treatment, many people who inject drugs still perceive numerous barriers to starting treatment, including the...